Delivery of intravenous anti-cancer therapy at home versus in hospital or community settings for adults with cancer

Liesl Grobler, Denise O'Connor, Danny Rischin, Polina Putrik, Jonathan Karnon, Kobi J. Rischin, Bayden J. McKenzie, Rachelle Buchbinder

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the safety, patient preference for, and cost of intravenous anti-cancer therapy (chemotherapy or immunotherapy) delivered at home as an alternative to the same intravenous anti-cancer therapy regimen delivered in a hospital or community settings, in adults with cancer.

Original languageEnglish
Article numberCD014861
Number of pages16
JournalCochrane Database of Systematic Reviews
Volume2022
Issue number5
DOIs
Publication statusPublished - 3 May 2022

Keywords

  • intravenous cancer therapy
  • chemotherapy
  • immunotherapy
  • Home based care
  • therapy at home
  • adults with cancer
  • hospital setting
  • community settings

Fingerprint

Dive into the research topics of 'Delivery of intravenous anti-cancer therapy at home versus in hospital or community settings for adults with cancer'. Together they form a unique fingerprint.

Cite this